Trial Name
Trial Number
Share this trial
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Toggle Content
Toggle Content
Toggle Content
Toggle Content
Toggle Content
Toggle Content
Toggle Content
Toggle Content
More to explore
TREAT CTC
TREAT CTC BIG 1-12 Share This Post TRastuzumab in HER2-negative Early breast cancer as Adjuvant Treatment for Circulating Tumor Cells (CTC) What Why / Objectives
DCIS
DCIS BIG 3-07 Share This Post An academic, investigator-led, randomised phase III study of radiation doses and treatment schedules in patients with non-low risk Ductal